STK11 and cancer: Loss or inactivation of LKB1 is a recurrent event in a variety of human cancers, such as lung adenocarcinoma, cervical carcinoma, and melanoma (Wingo et al., 2009; Liu et al., 2012; Mével-Aliset et al., 2025).